24/7 eTV BreakingNewsShow : Click on the volume button (lower left of the video screen)
Click here if this is your press release!

Losartan High Blood Pressure Medication Now Recalled

Written by editor

Mint Pharmaceuticals Inc. is recalling all lots of its prescription losartan tablets, in 50 mg and 100 mg strengths, after tests found an azido impurity (5-(4′-((5-(azidomethyl)-2-butyl-4-chloro-1H imidazol-1-yl)methyl)-[1,1′-biphenyl]-2-yl)-1H tetrazole) above the acceptable limit. Long-term exposure to the impurity at levels above what is considered safe could potentially increase the risk of cancer.

Print Friendly, PDF & Email

Please see the full advisory for more information, including what Canadians should do and Health Canada’s work to address the issue of azido impurities found in certain drugs.

ProductCompanyDINLotExpiry
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006959April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006960April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006961April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006962April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005006963April 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005011154June 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETSMint Pharmaceuticals Inc.023896572005011156June 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMint Pharmaceuticals Inc.023896652005006807April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMint Pharmaceuticals Inc.023896652005006808April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMint Pharmaceuticals Inc.023896652005006809April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETSMint Pharmaceuticals Inc.023896652005006810April 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETS Mint Pharmaceuticals Inc.023896652105002149December 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731805012687October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731805012688October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731805012689October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731805012792October 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896731905001010December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Mint Pharmaceuticals Inc.023896731905001011December 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005006947April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005006949April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005006950April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005006951April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETS Mint Pharmaceuticals Inc.023896732005007297April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005007298April 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732005013776August 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.023896732105002150December 2023
Print Friendly, PDF & Email

About the author

editor

Editor in chief is Linda Hohnholz.

Leave a Comment